Hetero Labs Limited
UkraineAll drugs from this manufacturer
-
The drug is intended for monotherapy in adults and children aged 10 years and older with highly active relapsing-remitting multiple sclerosis. This applies to patients for whom previous treatment has been ineffective, or those experiencing frequent exacerbations or new lesions on MRI.
Dosage form: capsules
Active substance Dosage fingolimod 0.5 mg ATC: L04AA27
-
The drug is intended for the treatment of influenza, as well as for the prevention of influenza after contact with an infected person or during a seasonal epidemic. It acts only against influenza viruses.
Dosage form: capsules
Active substance Dosage oseltamivir 30 mg ATC: J05AH02
-
The drug is intended for the treatment of influenza, as well as for the prevention of influenza after contact with an infected person or during a seasonal epidemic.
Dosage form: capsules
Active substance Dosage oseltamivir 45 mg ATC: J05AH02
-
The drug is intended for the treatment of influenza, as well as for the prevention of influenza after contact with an infected person or during a seasonal epidemic.
Dosage form: capsules
Active substance Dosage oseltamivir 75 mg ATC: J05AH02
-
The drug is used for the treatment of influenza, as well as for its prevention (after contact with an infected person or during epidemics). It acts only against influenza viruses.
Dosage form: powder for oral suspension
Active substance Dosage oseltamivir 6 mg/ml ATC: J05AH02
-
The drug is indicated for the treatment of adult patients with relapsing-remitting multiple sclerosis.
Dosage form: capsules, modified release
Active substance Dosage dimethyl fumarate 120 mg ATC: L04AX07
-
The drug is indicated for the treatment of adult patients with relapsing-remitting multiple sclerosis.
Dosage form: capsules, modified release
Active substance Dosage dimethyl fumarate 240 mg ATC: L04AX07
-
The drug is used to treat cytomegalovirus retinitis in patients with AIDS, as well as to prevent CMV infection in individuals who have undergone organ transplantation from CMV-positive donors.
Dosage form: tablets, film-coated
Active substance Dosage valganciclovir 450 mg ATC: J05AB14
-
The drug is prescribed for the treatment of bladder cancer, pancreatic cancer, non-small cell lung cancer, ovarian cancer, and breast cancer.
Dosage form: powder for solution for infusion
Active substance Dosage gemcitabine 1.0 g ATC: L01BC05
-
The drug is used for the treatment of bladder cancer, pancreatic cancer, non-small cell lung cancer, ovarian cancer, and breast cancer.
Dosage form: powder for solution for infusion
Active substance Dosage gemcitabine 200 mg ATC: L01BC05
-
The drug is prescribed for the treatment of chronic myeloid leukemia (CML), acute lymphoblastic leukemia (Ph+ ALL), myelodysplastic/myeloproliferative diseases (MDS/MPD), hypereosinophilic syndrome (HES), and chronic eosinophilic leukemia (CEL). It is also used for the treatment of gastrointestinal stromal tumors (GIST) and dermatofibrosarcoma protuberans (DFSP).
Dosage form: tablets, film-coated
Active substance Dosage imatinib 100 mg ATC: L01XE01
-
The drug is used to treat chronic myeloid leukemia (CML), acute lymphoblastic leukemia (Ph+ ALL), myelodysplastic/myeloproliferative neoplasms (MDS/MPD), hypereosinophilic syndrome (HES), and chronic eosinophilic leukemia (CEL). It is also indicated for the treatment of gastrointestinal stromal tumors (GIST) and dermatofibrosarcoma protuberans (DFSP).
Dosage form: tablets, film-coated
Active substance Dosage imatinib 400 mg ATC: L01XE01
-
The drug is used to treat high blood pressure (arterial hypertension) in adults. It is also prescribed for the treatment of chronic kidney disease in adult patients with arterial hypertension and type 2 diabetes mellitus.
Dosage form: tablets, film-coated
Active substance Dosage irbesartan 75 mg ATC: C09CA04
-
The drug is used to treat high blood pressure (arterial hypertension) in adults. It is also indicated for the treatment of chronic kidney disease in adult patients with arterial hypertension and type 2 diabetes mellitus.
Dosage form: tablets, film-coated
Active substance Dosage irbesartan 150 mg ATC: C09CA04
-
The drug is used to treat arterial hypertension (high blood pressure) in adults. It is also prescribed for the treatment of chronic kidney disease in adult patients with arterial hypertension and type 2 diabetes mellitus.
Dosage form: tablets, film-coated
Active substance Dosage irbesartan 300 mg ATC: C09CA04
-
The drug is used for the treatment of metastatic colorectal cancer. It may be used either as monotherapy or in combination with other drugs (e.g., 5-fluorouracil, folinic acid, cetuximab, bevacizumab, or capecitabine) depending on the treatment regimen and the patient's previous experience.
Dosage form: concentrate for infusion solution
Active substance Dosage irinotecan 20 mg/ml ATC: L01CE02
-
It is used for the treatment of adult patients with hormone-refractory metastatic prostate cancer who have previously undergone treatment with a docetaxel-based regimen. The drug is prescribed in combination with prednisone or prednisolone.
Dosage form: concentrate for infusion solution
Active substance Dosage cabazitaxel 60 mg in 1.5 ml 40 mg/ml ATC: L01CD04
-
The drug is used for the symptomatic treatment of seasonal allergic rhinitis (including perennial) and chronic idiopathic urticaria in adults and children aged 6 years and older.
Dosage form: tablets, film-coated
Active substance Dosage levocetirizine 5 mg ATC: R06AE09
-
The drug is used for the symptomatic treatment of allergic rhinitis (including perennial) and urticaria in adults and children aged 2 years and older.
Dosage form: solution, oral
Active substance Dosage levocetirizine 2.5 mg/5 ml ATC: R06AE09
-
The drug is prescribed for the treatment of essential hypertension (high blood pressure) of mild to moderate severity.
Dosage form: tablets, film-coated
Active substance Dosage lercanidipine 10 mg ATC: C08CA13
-
The drug is prescribed for the treatment of mild to moderate essential hypertension (high blood pressure).
Dosage form: tablets, film-coated
Active substance Dosage lercanidipine 20 mg ATC: C08CA13
-
The drug is used for hormone therapy in postmenopausal women with various forms of breast cancer (adjuvant therapy, treatment of advanced forms after recurrence, or neoadjuvant therapy).
Dosage form: tablets, film-coated
Active substance Dosage letrozole 2.5 mg ATC: L02BG04
-
The drug is used for the treatment of epilepsy. It is prescribed as monotherapy for partial seizures in adults and adolescents aged 16 and older, as well as adjunctive therapy for children from 6 years of age, adolescents, and adults with various forms of seizures (partial, myoclonic, or generalized).
Dosage form: tablets, film-coated
Active substance Dosage levetiracetam 250 mg ATC: N03AX14
-
The drug is used for the treatment of epilepsy. In adults and adolescents aged 16 and older, it may be used as monotherapy for partial seizures. It is also prescribed as adjunctive therapy for the treatment of partial seizures, myoclonic seizures, and generalized seizures in various age groups.
Dosage form: tablets, film-coated
Active substance Dosage levetiracetam 500 mg ATC: N03AX14
-
The drug is used for the treatment of epilepsy. It can be used as monotherapy for partial seizures in adults and adolescents aged 16 and older, as well as adjunctive therapy for children from 6 years of age, adolescents, and adults with various forms of seizures (partial, myoclonic, or generalized).
Dosage form: tablets, film-coated
Active substance Dosage levetiracetam 1000 mg ATC: N03AX14
-
The drug is used for the symptomatic treatment of allergic rhinitis (including perennial) and urticaria.
Dosage form: tablets, film-coated
Active substance Dosage levocetirizine 5 mg ATC: R06AE09
-
The drug is used for the treatment of adult patients with multiple myeloma, myelodysplastic syndromes (MDS), mantle cell lymphoma, and follicular lymphoma.
Dosage form: capsules, hard
Active substance Dosage lenalidomide 5 mg ATC: L04AX04
-
The drug is used for the treatment of adult patients with multiple myeloma, myelodysplastic syndromes (MDS), mantle cell lymphoma, and follicular lymphoma.
Dosage form: capsules, hard
Active substance Dosage lenalidomide 10 mg ATC: L04AX04
-
The drug is prescribed for the treatment of adult patients with multiple myeloma, myelodysplastic syndromes (MDS), mantle cell lymphoma (MCL), and follicular lymphoma (FL).
Dosage form: capsules, hard
Active substance Dosage lenalidomide 25 mg ATC: L04AX04
-
The drug is prescribed for the treatment of nosocomial and non-nosocomial pneumonia, complicated and uncomplicated skin and skin structure infections, as well as infections caused by vancomycin-resistant strains.
Dosage form: tablets, film-coated
Active substance Dosage linezolid 600 mg ATC: J01XX08
-
The drug is used to treat elevated cholesterol levels (hypercholesterolemia) in adults, adolescents, and children from 6 years of age, as well as for the prevention of cardiovascular disorders in high-risk patients.
Dosage form: tablets, film-coated
Active substance Dosage rosuvastatin 5 mg ATC: C10AA07
-
The drug is used to treat elevated cholesterol and triglyceride levels (hypercholesterolemia), as well as to prevent cardiovascular disorders in high-risk patients.
Dosage form: tablets, film-coated
Active substance Dosage rosuvastatin 10 mg ATC: C10AA07
-
The drug is used to treat elevated cholesterol and triglyceride levels (hypercholesterolemia), as well as to prevent cardiovascular disorders in high-risk patients.
Dosage form: tablets, film-coated
Active substance Dosage rosuvastatin 20 mg ATC: C10AA07
-
The drug is used to treat elevated cholesterol and triglyceride levels (hypercholesterolemia), as well as to prevent cardiovascular disorders in high-risk patients.
Dosage form: tablets, film-coated
Active substance Dosage rosuvastatin 40 mg ATC: C10AA07
-
It is used for the prevention of acute organ rejection in patients following kidney, heart, or liver transplantation. The drug is used as part of combination therapy together with cyclosporine and corticosteroids.
Dosage form: capsules
Active substance Dosage mycophenolate mofetil 250 mg ATC: L04AA06
-
The drug is used as add-on treatment for bronchial asthma (if it is not sufficiently controlled by other agents), for the prevention of exercise-induced asthma, and to relieve the symptoms of seasonal and perennial allergic rhinitis.
Dosage form: tablets, film-coated
Active substance Dosage montelukast 10 mg ATC: R03DC03
-
The drug is used as add-on treatment for bronchial asthma (if it is not sufficiently controlled by other agents), for the prevention of exercise-induced asthma, and to relieve the symptoms of seasonal and perennial allergic rhinitis.
Dosage form: tablets, chewable
Active substance Dosage montelukast 5 mg ATC: R03DC03
-
The drug is used to treat bacterial infections in adults, specifically acute bacterial sinusitis, exacerbation of chronic obstructive pulmonary disease (including bronchitis), non-hospital pneumonia, and inflammatory diseases of the pelvic organs.
Dosage form: tablets, film-coated
Active substance Dosage moxifloxacin 400 mg ATC: J01MA14
-
It is used to enhance the mobilization of stem cells into the blood for subsequent collection and transplantation. The drug is prescribed to adults with lymphoma or multiple myeloma, as well as children (from 1 to 18 years old) with lymphoma or solid tumors.
Dosage form: solution for injection
Active substance Dosage plerixafor 20 mg/ml ATC: L03AX16
-
The drug is used for the treatment of ovarian cancer, breast cancer, progressive non-small cell lung cancer, as well as Kaposi's sarcoma in patients with AIDS.
Dosage form: concentrate for infusion solution
Active substance Dosage paclitaxel 6 mg/ml ATC: L01CD01
-
The drug is used to treat reflux esophagitis (related to GERD), to maintain remission of erosive esophagitis, and to treat conditions accompanied by excessive gastric acid production, such as Zollinger-Ellison syndrome.
Dosage form: tablets, enteric-coated
Active substance Dosage pantoprazole 20 mg ATC: A02BC02
-
The drug is used to treat reflux esophagitis (related to GERD), to maintain remission of erosive esophagitis, and to treat conditions accompanied by excessive gastric acid secretion, specifically Zollinger-Ellison syndrome.
Dosage form: tablets, enteric-coated
Active substance Dosage pantoprazole 40 mg ATC: A02BC02
-
The drug is prescribed for the treatment of malignant pleural mesothelioma, as well as non-small cell non-squamous lung cancer (both in combination with cisplatin and as monotherapy for maintenance or second-line therapy).
Dosage form: powder for solution for infusion
Active substance Dosage pemetrexed 500 mg ATC: L01BA04
-
The drug is indicated for the treatment of malignant unresectable pleural mesothelioma, as well as non-small cell non-squamous lung cancer (both in combination with cisplatin and as monotherapy for maintenance or second-line treatment).
Dosage form: powder for solution for infusion
Active substance Dosage pemetrexed 100 mg ATC: L01BA04
-
The drug is used for the treatment of adults with invasive aspergillosis, fusariosis, chromoblastomycosis, mycetoma, and coccidioidomycosis (if patients have resistance or intolerance to other medications). It is also prescribed for the prevention of invasive fungal infections in patients undergoing chemotherapy or stem cell transplantation.
Dosage form: tablets, enteric-coated
Active substance Dosage posaconazole 100 mg ATC: J02AC04
-
The drug is used as part of combination therapy for the treatment of HIV-1-infected patients (both adults and children aged 2 years and older).
Dosage form: tablets, film-coated
Active substance Dosage ritonavir 100 mg ATC: J05AE03
-
The drug is used for the treatment of patients with HIV infection in combination with other antiviral agents.
Dosage form: tablets, film-coated
Active substance Dosage lopinavir 200 mg ritonavir 50 mg ATC: J05AR10
-
The drug is intended for the treatment of adults with chronic hepatitis C. It should be used only in combination with other medicinal products.
Dosage form: tablets, film-coated
Active substance Dosage sofosbuvir 400 mg ATC: J05AP08
-
The drug is intended for the treatment of chronic hepatitis C in adults and children aged 12 to 18 years.
Dosage form: tablets, film-coated
Active substance Dosage ledipasvir 90 mg sofosbuvir 400 mg ATC: J05AP51
-
The drug is intended for the treatment of adults with chronic hepatitis C (HCV).
Dosage form: tablets, film-coated
Active substance Dosage sofosbuvir 400 mg velpatasvir 100 mg ATC: J05AP55